The effect of hyperglycemia on neonatal immune responses in-vitro

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 1, 2012, Pages 94-98

  Temming, Petra ^a,d   Tröger, Birte ^a   Thonnissen, Susanne ^a,c   Holterhus, Paul Martin ^b   Schultz, Christian ^a   Härtel, Christoph ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b ST BONIFATIUS HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

cytokines; endocrine immunology; flow cytometry; Neonatal

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GESTATIONAL AGE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNE RESPONSE; IN VITRO STUDY; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

CYTOKINES; FETAL BLOOD; GESTATIONAL AGE; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INSULIN; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84055211789     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.557106     Document Type: Conference Paper

References (47)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891. (Pubitemid 36019643)
2. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8. (Pubitemid 27276750)
3. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG. High expression of tumor necrosis factor-alpha and interleukin- 6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-411. (Pubitemid 27385721)
4. Yoon BH, Romero R, Kim KS, Park J S, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-779. (Pubitemid 29503589)
5. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-830. (Pubitemid 27516049)
6. Schultz C, Rott C, Temming P, Schlenke P, Moller JC, Bucsky P. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002;51:317-322. (Pubitemid 34174967)
7. Dembinski J, Behrendt D, Martini R, Heep A, Bartmann P. Modulation of pro- and anti-inflammatory cytokine production in very preterm infants. Cytokine 2003;21:200-206. (Pubitemid 36681542)
8. Devaraj S, Venugopal SK, Singh U, Jialal I. Hyperglycemia induce monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and {beta}. Diabetes 2005;54:85-91. (Pubitemid 40105098)
9. Hancu N, Netea MG, Baciu I. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Rom J Physiol 1998;35:325-330.
10. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucosedependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996;45:954-959. (Pubitemid 26225513)
11. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118:1811-1818. (Pubitemid 46393660)
12. Kao LS, Morris BH, Lally KP, Stewart CD, Huseby V, Kennedy KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006;26:730-736. (Pubitemid 44811506)
13. Schultz C. Intracytoplasmic detection of proinflammatory cytokines and chemokines in monocytes by flow cytometry. MethodsMol Biol 2003;215:29-39.
14. Schultz C, Rott C, Temming P, von Puttkammer J, Bucsky P. Influence of specimen age and use of different negative controls in determination of intracytoplasmic levels of cytokines after whole-blood culture assay. Clin Diagn Lab Immunol 2002;9:295-298. (Pubitemid 34226020)
15. McGuinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr 2005;25:9-35. (Pubitemid 41208992)
16. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995;98:75-84.
17. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001;15:533-551.
18. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schet M, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
19. Langouche L, Vanhorebeek I, Van den Berghe G. Therapy insight: the effect of tight glycemic control in acute illness. Nat Clin Pract Endocrinol Metab 2007;3:270-278.
20. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J, Bistrian BR. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997;21:91-95. (Pubitemid 27136782)
21. Rassias AJ, Givan AL, Marrin CA, Whalen K, Pahl J, Yeager MP. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002;94:1113-1119. (Pubitemid 34441817)
22. Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999;88:1011-1016. (Pubitemid 29211530)
23. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003;88:1082-1088. (Pubitemid 36337759)
24. Duggan PJ, Maalouf EF, Watts TL, Sullivan MH, Counsell SJ, Allsop J, Al-Nakib L, Rutherford MA, Battin M, Roberts I, et al. . Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001;358:1699-1700. (Pubitemid 33124333)
25. Schultz C, Temming P, Bucsky P, Gopel W, Strunk T, Hartel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004;135:130-136. (Pubitemid 38067937)
26. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994;36:244-252. (Pubitemid 24222488)
27. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, Syn HC. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-1440. (Pubitemid 26165257)
28. Schultz C, Tautz J, Reiss I, Moller JC. Prolonged mechanical ventilation induces pulmonary inflammation in preterm infants. Biol Neonate 2003;84:64-66. (Pubitemid 36928733)
29. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns - dry numbers, wet lab, and causal inferences. Early Hum Dev 2004;79:1-15. (Pubitemid 39036744)
30. de Galan BE, Netea MG, Smits P, van der Meer JW. Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-alpha, but does not affect IL-1beta, IL-6, or IL-10. Cytokine 2003;22:71-76. (Pubitemid 36808764)
31. Pieper GM, Riaz-ul H. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 1997;30:528-532. (Pubitemid 27527591)
32. Cameron NE, Cotter MA. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets 2008;9:60-67. (Pubitemid 351209290)
33. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. . Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-366. (Pubitemid 36232926)
34. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000. (Pubitemid 39007018)
35. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. . Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461. (Pubitemid 43200296)
36. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047. (Pubitemid 37430587)
37. NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, Blair D, Foster D. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
38. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004;5:329-336.
39. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006;118:173-179. (Pubitemid 46071160)
40. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005;146:30-34. (Pubitemid 40091727)
41. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-1478. (Pubitemid 37475630)
42. Alexandrou G, Skiöld B, Karlén J, Tessma MK, Norman M, Adén U, Vanpée M. Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants. Pediatrics 2010;125:e584-e591.
43. Dandona P, Aljada A, Dhindsa S, Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin Cornerstone 2003;(Suppl 4):S13-S20. (Pubitemid 38180826)
44. Rozance PJ, Hay WW. Hypoglycemia in newborn infants: features associated with adverse outcomes. Biol Neonate 2006;90:74-86. (Pubitemid 44197473)
45. Hawdon JM. Hypoglycaemia and the neonatal brain. Eur J Pediatr 1999;158 (Suppl 1):S9-S12.
46. Kashyap S, Polin RA. Insulin infusions in very-low-birth-weight infants. N Engl J Med 2008;359:1951-1953.
47. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, van Weissenbruch M, et al. . Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008;359:1873-1884.